KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $12.4 million.

  • Dynavax Technologies' Share-based Compensation fell 529.7% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 million, marking a year-over-year increase of 373.89%. This contributed to the annual value of $52.6 million for FY2024, which is 2354.2% up from last year.
  • Per Dynavax Technologies' latest filing, its Share-based Compensation stood at $12.4 million for Q3 2025, which was down 529.7% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Share-based Compensation ranged from a high of $14.5 million in Q1 2025 and a low of $4.7 million during Q1 2021
  • In the last 5 years, Dynavax Technologies' Share-based Compensation had a median value of $10.6 million in 2023 and averaged $10.0 million.
  • In the last 5 years, Dynavax Technologies' Share-based Compensation skyrocketed by 16563.55% in 2021 and then tumbled by 529.7% in 2025.
  • Dynavax Technologies' Share-based Compensation (Quarter) stood at $6.2 million in 2021, then surged by 41.63% to $8.7 million in 2022, then rose by 29.59% to $11.3 million in 2023, then grew by 14.99% to $13.0 million in 2024, then dropped by 4.72% to $12.4 million in 2025.
  • Its Share-based Compensation stands at $12.4 million for Q3 2025, versus $13.0 million for Q2 2025 and $14.5 million for Q1 2025.